Status:
NOT_YET_RECRUITING
Translation and Validation of the Hypoparathyroidism Patient Experience Scales (HPES) Questionnaire in Greek
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
National and Kapodistrian University of Athens
424 General Military Hospital
Conditions:
Hypoparathyroidism
Eligibility:
All Genders
18-80 years
Brief Summary
This is a crossectional study that will be conducted at several tertiary centers in Greece. To participate in the study, patients should be ≥18 years of age, fluent in Greek language, diagnosed with ...
Detailed Description
1. Background Hypoparathyroidism (HP) is a chronic disease, characterized by hypocalcemia and hyperphosphatemia, due to low, or inappropriately normal, concentrations of parathyroid hormone (PTH). It ...
Eligibility Criteria
Inclusion
- Patients should be ≥18 years of age, fluent in Greek language, diagnosed with chronic HP, on optimal treatment with calcium and active vitamin D metabolites. Chronic HP is defined when continuous therapy with calcium and vitamin D is required for \>12 months.
Exclusion
- Patients inadequately controlled with conventional therapy:
- corrected serum Ca (cCa) ≤8 mg/dl or cCa ≤8.2 mg/dl with symptoms of hypocalcemia
- serum P \>5.5 mg/dl
- Age \>80 years
- Presence of neoplastic disease
- Pregnancy
- Diagnosis of psychiatric disease or cognitive impairment
- Participants experiencing other comorbidities that may affect QoL
- Lack of informed consent
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07160348
Start Date
October 1 2025
End Date
April 1 2026
Last Update
September 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.